Public-registry site landscape for NCT06003751, a Diabetic Retinopathy study sponsored by Perfuse Therapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT06003751 (registry record) |
| Sponsor | Perfuse Therapeutics, Inc. |
| Condition(s) | Diabetic Retinopathy |
| Phase | PHASE2 |
| Listed sites | 1 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT06003751 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →